Nanjing Vazyme Biotech Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: 0.79x

Nanjing Vazyme Biotech Co Ltd free cash flow generation index. Nanjing Vazyme Biotech Co Ltd (688105) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥59.46 Million represents 1% of operating cash flow (CN¥75.30 Million).

FCF Generation Index

0.79x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥59.46 Million
CNY

Operating Cash Flow

CN¥75.30 Million
CNY

Capital Expenditures

CN¥15.83 Million
CNY

Free Cash Flow Generation Index of Nanjing Vazyme Biotech Co Ltd (2019–2025)

Free cash flow generation index of Nanjing Vazyme Biotech Co Ltd from 2019 to 2025. Historical FCF Generation Index trend for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. See financial flexibility index of Nanjing Vazyme Biotech Co Ltd to measure the company's free cash flow as a share of total liabilities.

Nanjing Vazyme Biotech Co Ltd Free Cash Flow Generation Index by Year (2019–2025)

Nanjing Vazyme Biotech Co Ltd free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for Nanjing Vazyme Biotech Co Ltd. For the full cash flow conversion analysis, see Nanjing Vazyme Biotech Co Ltd operating cash flow efficiency.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.80x CN¥185.77 Million CN¥233.16 Million CN¥47.39 Million ▲ +297.8%
2023 -0.40x CN¥-79.91 Million CN¥198.40 Million CN¥232.90 Million ▼ -30.0%
2022 -0.31x CN¥-227.69 Million CN¥735.17 Million CN¥962.86 Million ▼ -153.8%
2021 0.58x CN¥354.84 Million CN¥616.80 Million CN¥261.96 Million ▼ -29.0%
2020 0.81x CN¥651.01 Million CN¥803.55 Million CN¥152.54 Million ▲ +363.2%
2019 -0.31x CN¥-4.68 Million CN¥15.20 Million CN¥19.88 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).